Health professionals

Uterine cancer survival statistics

Uterine cancer survival has increased in the last 50 years in the UK, and it is predicted that more than 7 in 10 (71.7%) females diagnosed with uterine cancer in the UK survive their disease for ten years or more (2018). Five-year relative survival for uterine cancer in women is similar to the European average in England, Wales, Scotland and Northern Ireland.

For uterine cancer, like other cancer sites, survival trends reflect a combination of changes in treatment and stage distribution. These factors themselves can vary by age, sex and deprivation.

Our data hubs below offer an in-depth breakdown of the most up to date cancer statistics.

*These statistics are aimed at supporting health professionals, academics, researchers and media. If you are a patient or carer, you may want to visit our public facing webpages.

Icon of a lowercase white letter I in a blue circle.

Uterine cancer survival by age

8 in 10 (80.1%) females in the UK diagnosed with uterine cancer aged 15-44 survive their disease for ten years or more, compared with almost 6 in 10 (54.8%) females diagnosed aged 75-99 (2018).

Explore more detailed age stats on our data hub for uterine cancer

Icon_head and shoulders person_navy.

Uterine cancer survival by deprivation

7 in 10 (69.6%) women diagnosed with uterine cancer in the most deprived group in England survive their disease for five years or more, compared with almost 8 in 10 (77.9%) in the least deprived group (2018-2022).

Explore more detailed deprivation stats on our data hub for uterine cancer

Navy icon of a graph and a trending up arrow.

Uterine cancer survival trends by time

In the 1970s, almost 6 in 10 (55.6%) females diagnosed with uterine cancer survived their disease beyond ten years, by 2018 it was more than 7 in 10 (71.7%).

Explore more detailed trends stats on our data hub for uterine cancer

Icon of a lowercase white letter I in a blue circle.

Uterine cancer survival trends by age

Uterine cancer ten-year survival has increased in women in all broad age groups since the early 1970s.

Explore more detailed trends by age stats on our data hub for uterine cancer

Icon of a navy calendar.

Uterine conditional survival statistics

Around 3 in 4 (76%) women diagnosed with uterine cancer in England survive their disease for five years or more (2015-2019). For women who have already survived for one year, almost 9 in 10 (84.7%) survive their disease for five years or more (2015-2019).

Explore more detailed conditional survival stats on our data hub for uterine cancer

More uterine cancer statistics

Statistics by cancer type

View our latest cancer statistics including key stats, in-depth explanations and raw data on cancer incidence, mortality, survival, risk, and diagnosis and treatment.

View full A-Z cancer statistics

Cancer stats explained

Find information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Local cancer statistics

Go to local cancer statistics - search profiles by area, constituency or health board in the UK.

Citation

You are welcome to reuse this Cancer Research UK content for your own work. When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

  • Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].

  • Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.

  • Graphics (when reused unaltered): Credit: Cancer Research UK.

  • Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

Ways to donate

Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or follow the link to donate online.

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used.

Find out more about the sources which are essential for our statistics